FDA panel recommends approval of ReSure Sealant with some concerns

GAITHERSBURG, Md. — The Ophthalmic Devices Panel of the U.S. Food and Drug Administration voted to recommend approval of ReSure Sealant.Members overwhelmingly affirmed the product’s safety and benefit-risk profile. However, some members voiced concern about safety, indications, labeling and postmarket study criteria.

Full Story →